Effexor xr and Keloids - a phase IV clinical study of FDA data
Keloids is reported only by a few people who take Effexor Xr.
The phase IV clinical study analyzes which people take Effexor xr and have Keloids. It is created by eHealthMe based on reports of 30,721 people who have side effects while taking Effexor xr from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
30,721 people reported to have side effects when taking Effexor xr.
Among them, 1 person (0.0%) has Keloids.
What is Effexor xr?
Effexor xr has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 34,581 Effexor xr users for its effectiveness, alternative drugs and more.
What is Keloids?
Keloids (overgrown scars left from skin injuries) is found to be associated with 629 drugs and 446 conditions by eHealthMe.
Number of Effexor xr and Keloids reports submitted per year:
Time on Effexor xr when people have Keloids *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 100 %
- 10+ years: 0.0 %
Gender of people who have Keloids when taking Effexor xr *:
- female: 100 %
- male: 0.0 %
Age of people who have Keloids when taking Effexor xr *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common side effects people have besides Keloids *:
- Respiratory Tract Inflammation: 1 person, 100.00%
- Purpura (purplish discoloration of the skin): 1 person, 100.00%
- Inflammation: 1 person, 100.00%
- Hypersensitivity: 1 person, 100.00%
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 100.00%
- Cystitis Noninfective (non-infectious inflammation of the wall of the bladder): 1 person, 100.00%
- Bleeding Into The Skin: 1 person, 100.00%
- Bleeding Disorders: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Effexor xr and have Keloids?Check whether Keloids is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keloids and when was it recovered:
Expand to all the drugs that have ingredients of venlafaxine hydrochloride:
Alternative drugs to, pros and cons of Effexor xr:
- Effexor xr (34,581 reports)
Common Effexor xr side effects:
- Stress and anxiety: 2,666 reports
- Dizziness: 2,487 reports
- Drug ineffective: 2,362 reports
- Depression: 2,301 reports
- Headache (pain in head): 2,272 reports
- Fatigue (feeling of tiredness): 1,980 reports
Browse all side effects of Effexor xr:a b c d e f g h i j k l m n o p q r s t u v w x y z
Keloids treatments and more:
- Keloids (1,005 reports)
COVID vaccines that are related to Keloids:
- Keloids in Moderna COVID Vaccine
- Keloids in Pfizer BioNTech Covid Vaccine
- Keloids in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keloids:
- Keloids (629 drugs)
All the conditions that are associated with Keloids:
- Keloids (446 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor xr) and Effexor xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ketotifen Fumarate and Diplopia - 3 seconds ago
- Darvon and Respiratory Moniliasis - 16 seconds ago
- Esomeprazole Sodium and Lichenoid Keratosis - 34 seconds ago
- Cefprozil and Diarrhea Infectious - 35 seconds ago
- Profen and Granulocytes Abnormal - 37 seconds ago
- Sucralfate and Haematemesis - 37 seconds ago
- Dry Eyes and Breast Cancer Recurrent - 44 seconds ago
- Creon and Dexamethasone drug interaction - 45 seconds ago
- Atovaquone and Myopathy - 48 seconds ago
- Enalapril Maleate and Convulsions - 48 seconds ago